Canada Life’s PDL BioPharma, Inc. PDLI Stock Holding History

Canada Life’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,578	Closed	-$27K	–	2699
2020 Q3	$27K	Hold	8,578	–	–	﹤0.01%	2369
2020 Q2	$25K	Hold	8,578	–	–	﹤0.01%	2456
2020 Q1	$24K	Hold	8,578	–	–	﹤0.01%	2341
2019 Q4	$28K	Buy	+8,578	New	+$24.9K	﹤0.01%	2433
2019 Q3	–	Sell	-16,167	Closed	-$50K	–	2744
2019 Q2	$50K	Hold	16,167	–	–	﹤0.01%	2445
2019 Q1	$60K	Hold	16,167	–	–	﹤0.01%	2218
2018 Q4	$45K	Hold	16,167	–	–	﹤0.01%	2414
2018 Q3	$43K	Hold	16,167	–	–	﹤0.01%	2428
2018 Q2	$38K	Hold	16,167	–	–	﹤0.01%	2457
2018 Q1	$48K	Hold	16,167	–	–	﹤0.01%	2383
2017 Q4	$44K	Hold	16,167	–	–	﹤0.01%	2399
2017 Q3	$55K	Hold	16,167	–	–	﹤0.01%	2317
2017 Q2	$40K	Hold	16,167	–	–	﹤0.01%	2388
2017 Q1	$36K	Hold	16,167	–	–	﹤0.01%	2381
2016 Q4	$34K	Hold	16,167	–	–	﹤0.01%	2411
2016 Q3	$54K	Hold	16,167	–	–	﹤0.01%	2320
2016 Q2	$51K	Hold	16,167	–	–	﹤0.01%	2308
2016 Q1	$54K	Hold	16,167	–	–	﹤0.01%	2098
2015 Q4	$57K	Hold	16,167	–	–	﹤0.01%	2096
2015 Q3	$81K	Hold	16,167	–	–	﹤0.01%	1852
2015 Q2	$104K	Hold	16,167	–	–	﹤0.01%	1846
2015 Q1	$113K	Hold	16,167	–	–	﹤0.01%	1725
2014 Q4	$124K	Hold	16,167	–	–	﹤0.01%	1602
2014 Q3	$121K	Buy	16,167 +10,083	+166%	+$93.6K	﹤0.01%	1541
2014 Q2	$59K	Buy	6,084 +78	+1%	+$695	﹤0.01%	1876
2014 Q1	$49K	Hold	6,006	–	–	﹤0.01%	1809
2013 Q4	$51K	Buy	+6,006	New	+$50.6K	﹤0.01%	1782

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Canada Life's PDLI Position: Q4 2020 in Review

Canada Life sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 8,578 shares — an estimated $27K sold.

Canada Life first reported a position in PDLI in Q4 2013 and held it in 27 quarters. The position peaked at $124K in Q4 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Canada Life reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Canada Life sold 8,578 PDL BioPharma, Inc. shares in Q4 2020, an estimated $27K.
Canada Life first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 27 quarters.
Canada Life's PDL BioPharma, Inc. position peaked at $124K in Q4 2014.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Canada Life's 13F filing for Q4 2020, filed 16 Feb 2021.